mefloquine has been researched along with Mastocytosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergström, A; Hagforsen, E; Lampinen, M; Lara-Valencia, P; Levedahl, KH; Paivandy, A; Pejler, G; Rollman, O; Weström, S | 1 |
1 other study(ies) available for mefloquine and Mastocytosis
| Article | Year |
|---|---|
Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway.
Topics: Adult; Apoptosis; Caspases; Humans; Mast Cells; Mastocytosis; Mastocytosis, Cutaneous; Mefloquine; Secretory Vesicles | 2022 |